Suppr超能文献

晚期糖基化终产物通过诱导成骨细胞发生铁死亡促进骨质疏松症的发生。

Advanced glycation end products promote osteoporosis by inducing ferroptosis in osteoblasts.

机构信息

Department of Radiology, Pukou Branch of Jiangsu People's Hospital (Nanjing Pukou District Central Hospital), Nanjing, Jiangsu 210018, P.R. China.

Department of Orthopedics, Pukou Branch of Jiangsu People's Hospital (Nanjing Pukou District Central Hospital), Nanjing, Jiangsu 210018, P.R. China.

出版信息

Mol Med Rep. 2022 Apr;25(4). doi: 10.3892/mmr.2022.12656. Epub 2022 Feb 25.

Abstract

Advanced glycation end products (AGEs) have been widely reported to play an important role in osteoporosis (OP), particularly in diabetes‑related OP. The aim of the present study was to investigate the effect of AGEs on osteoblast function and the underlying mechanisms. The level of bone mineral density (BMD), serum AGEs and fasting blood glucose (FBG) was measured in patients with OP and healthy individuals, and the correlation between AGE levels and BMD or FBG was then analyzed. For the experiments, the hFOB1.19 osteoblast cell line was cultured in medium containing AGEs and serum from healthy individuals or patients with OP, and with or without type‑2 diabetes mellitus (T2DM). Cell proliferation, differentiation, mineralization, apoptosis and ferroptosis were evaluated using Cell Counting Kit‑8 and alkaline phosphatase (ALP) assays, Alizarin red and TUNEL staining, iron indicator, lipid peroxidation tests and western blot analysis, respectively. In a separate set of experiments, the ferroptosis inhibitor, deferoxamine (DFO), was also added to the culture medium of cells treated with AGEs and serum from patients with OP and T2DM. The results demonstrated that patients with OP had a higher level of serum AGEs and FBG compared with that in healthy individuals. The level of serum AGEs in patients with OP was negatively correlated with BMD, but was positively correlated with FBG. In addition, AGEs and serum from patients with OP markedly inhibited hFOB1.19 cell proliferation, ALP production and mineralized nodule formation. Apoptosis and ferroptosis were significantly promoted by AGEs and serum from patients with OP. Moreover, serum from OP patients with T2DM caused stronger effect than that from OP patients with normal FBG. However, DFO reversed the effects induced by AGEs and serum from patients with OP and T2DM on hFOB1.19 cells. Collectively, AGEs could disrupt the functions of osteoblasts by inducing cell ferroptosis, thus contributing to OP.

摘要

糖基化终产物(AGEs)已被广泛报道在骨质疏松症(OP)中发挥重要作用,尤其是在糖尿病相关的 OP 中。本研究旨在探讨 AGEs 对成骨细胞功能的影响及其潜在机制。检测了 OP 患者和健康个体的骨密度(BMD)、血清 AGEs 和空腹血糖(FBG)水平,并分析了 AGE 水平与 BMD 或 FBG 的相关性。在实验中,将 hFOB1.19 成骨细胞系培养在含 AGEs 和来自健康个体或 OP 患者的血清的培养基中,并在有无 2 型糖尿病(T2DM)的情况下进行培养。通过细胞计数试剂盒-8 和碱性磷酸酶(ALP)测定、茜素红和 TUNEL 染色、铁指示剂、脂质过氧化试验和 Western blot 分析分别评估细胞增殖、分化、矿化、凋亡和铁死亡。在另一组实验中,还将铁死亡抑制剂去铁胺(DFO)添加到用来自 OP 伴 T2DM 患者的 AGEs 和血清处理的细胞的培养基中。结果表明,OP 患者的血清 AGEs 和 FBG 水平高于健康个体。OP 患者的血清 AGEs 水平与 BMD 呈负相关,与 FBG 呈正相关。此外,AGEs 和来自 OP 患者的血清显著抑制 hFOB1.19 细胞增殖、ALP 产生和矿化结节形成。来自 OP 患者的 AGEs 和血清显著促进细胞凋亡和铁死亡。此外,来自伴有高 FBG 的 OP 患者的血清引起的作用强于来自伴有正常 FBG 的 OP 患者的血清。然而,DFO 逆转了来自 OP 伴 T2DM 患者的 AGEs 和血清对 hFOB1.19 细胞的作用。总之,AGEs 通过诱导细胞铁死亡破坏成骨细胞的功能,从而导致 OP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e3f/8908347/a21c4a7654c3/mmr-25-04-12656-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验